Duality Biotherapeutics (HKG:9606) made a stellar trading debut in Hong Kong on Tuesday morning as its shares soared over 91% at the opening bell, defying the stock market volatility caused by the tariff war between the world's two largest economies.
The Chinese biotech firm opened at HK$181 per share, well above its initial public offering price of HK$94.60. As of 10:41 a.m., Hong Kong time, the stock traded at HK$209.60.
The company's debut takes place against a backdrop of heightened uncertainty in global equity markets, driven by escalating US-China trade tensions.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。